Загрузка...
Long-term neuropsychological outcomes from an open-label phase 1/2a trial of 2-hydoxypropyl-β-cyclodextrins (VTS-270) in Niemann-Pick Disease, Type C1
BACKGROUND: Niemann-Pick disease, type C1 is a neurodegenerative condition that arises from mutations of NPC1 and is often diagnosed in children. Recently, several drug trials have been implemented to minimize neurodegeneration, including a trial of 2-hydoxypropyl-β-cyclodextrins (VTS-270). OBJECTIV...
Сохранить в:
| Опубликовано в: : | CNS Drugs |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7448545/ https://ncbi.nlm.nih.gov/pubmed/31187454 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40263-019-00642-2 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|